Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of insulin resistance (IR), is one of the most important causes of liver disease worldwide (1) and is the most common cause of abnormal alanine aminotransferase (ALT) (2). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.